WO2004043238A3 - Biomarkers for intra-amniotic inflammation - Google Patents

Biomarkers for intra-amniotic inflammation Download PDF

Info

Publication number
WO2004043238A3
WO2004043238A3 PCT/US2003/036120 US0336120W WO2004043238A3 WO 2004043238 A3 WO2004043238 A3 WO 2004043238A3 US 0336120 W US0336120 W US 0336120W WO 2004043238 A3 WO2004043238 A3 WO 2004043238A3
Authority
WO
WIPO (PCT)
Prior art keywords
biomarkers
intra
amniotic inflammation
amniotic
inflammation
Prior art date
Application number
PCT/US2003/036120
Other languages
French (fr)
Other versions
WO2004043238A2 (en
WO2004043238A8 (en
Inventor
Irina A Buhimschi
Robert Christner
Original Assignee
Ciphergen Biosystems Inc
Irina A Buhimschi
Robert Christner
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciphergen Biosystems Inc, Irina A Buhimschi, Robert Christner filed Critical Ciphergen Biosystems Inc
Priority to AU2003290775A priority Critical patent/AU2003290775A1/en
Priority to US10/534,694 priority patent/US20060127962A1/en
Priority to EP03783358A priority patent/EP1578205A4/en
Priority to JP2004552155A priority patent/JP2006511790A/en
Publication of WO2004043238A2 publication Critical patent/WO2004043238A2/en
Publication of WO2004043238A8 publication Critical patent/WO2004043238A8/en
Publication of WO2004043238A3 publication Critical patent/WO2004043238A3/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4721—Cationic antimicrobial peptides, e.g. defensins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4727—Calcium binding proteins, e.g. calmodulin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour

Abstract

Biomarkers are capable of identifying intra-amniotic inflammation. A single biomarker or combination of biomarkers can be used to qualify the risk of preterm delivery in a patient, provided that at least one of the biomarkers is a calgranulin, preferably calgranulin A or C. In particular, the concentrations of the biomarkers correlate with the magnitude of intra-amniotic inflammation and hence, of preterm delivery.
PCT/US2003/036120 2002-11-14 2003-11-13 Biomarkers for intra-amniotic inflammation WO2004043238A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
AU2003290775A AU2003290775A1 (en) 2002-11-14 2003-11-13 Biomarkers for intra-amniotic inflammation
US10/534,694 US20060127962A1 (en) 2002-11-14 2003-11-13 Biomarkers for intro-amniotic inflammation
EP03783358A EP1578205A4 (en) 2002-11-14 2003-11-13 Biomarkers for intro-amniotic inflammation
JP2004552155A JP2006511790A (en) 2002-11-14 2003-11-13 Biomarkers for intra-amniotic inflammation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42609602P 2002-11-14 2002-11-14
US60/426,096 2002-11-14

Publications (3)

Publication Number Publication Date
WO2004043238A2 WO2004043238A2 (en) 2004-05-27
WO2004043238A8 WO2004043238A8 (en) 2005-06-16
WO2004043238A3 true WO2004043238A3 (en) 2005-08-04

Family

ID=32313108

Family Applications (2)

Application Number Title Priority Date Filing Date
PCT/US2003/036120 WO2004043238A2 (en) 2002-11-14 2003-11-13 Biomarkers for intra-amniotic inflammation
PCT/US2003/036622 WO2004045379A2 (en) 2002-11-14 2003-11-13 Biomarkers for intra-amniotic inflammation

Family Applications After (1)

Application Number Title Priority Date Filing Date
PCT/US2003/036622 WO2004045379A2 (en) 2002-11-14 2003-11-13 Biomarkers for intra-amniotic inflammation

Country Status (5)

Country Link
US (2) US20060127962A1 (en)
EP (1) EP1578205A4 (en)
JP (1) JP2006511790A (en)
AU (2) AU2003290775A1 (en)
WO (2) WO2004043238A2 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7191068B2 (en) * 2003-03-25 2007-03-13 Proteogenix, Inc. Proteomic analysis of biological fluids
US8068990B2 (en) 2003-03-25 2011-11-29 Hologic, Inc. Diagnosis of intra-uterine infection by proteomic analysis of cervical-vaginal fluids
US20050233400A1 (en) * 2004-03-03 2005-10-20 Weiner Carl P Proteomic method for predicting success of rescue cerclage
US7659087B2 (en) * 2004-07-23 2010-02-09 Aspenbio Pharma, Inc. Methods and devices for diagnosis of appendicitis
JP4447641B2 (en) * 2004-07-23 2010-04-07 アスペンビオ， ファーマ， インコーポレイテッド Methods and devices for diagnosing appendicitis
EP1624074A1 (en) * 2004-08-06 2006-02-08 Neurolab Markers and methods for detecting prenatal chromosomal abnormalities
US20060094039A1 (en) * 2004-09-20 2006-05-04 Ron Rosenfeld Diagnosis of fetal aneuploidy
US7972802B2 (en) 2005-10-31 2011-07-05 University Of Washington Lipoprotein-associated markers for cardiovascular disease
US20100137263A1 (en) * 2006-10-20 2010-06-03 Newcastle Innovation Limited Assay for the detection of biomarkers associated with pregnancy related conditions
JP5363481B2 (en) * 2007-07-20 2013-12-11 ザ ユニバーシティ オブ ユタ リサーチ ファウンデーション Biomarker identification and quantification to assess the risk of preterm birth
US20110144076A1 (en) * 2008-05-01 2011-06-16 Michelle A Williams Preterm delivery diagnostic assay
US8241861B1 (en) 2008-07-08 2012-08-14 Insilicos, Llc Methods and compositions for diagnosis or prognosis of cardiovascular disease
EP2467716B1 (en) * 2009-08-20 2015-01-28 University of Utah Research Foundation Identification and quantification of biomarkers for evaluating the risk of preterm birth
CA2850366A1 (en) * 2011-09-30 2013-04-04 The Research Institute At Nationwide Children's Hospital Compositions and methods for detection of defensins in a patient sample
CN104535771A (en) * 2014-12-19 2015-04-22 武汉市星熠艾克生物医药有限责任公司 Human alpha-defensin peptide enzyme linked immunosorbent assay kit
CN115015552A (en) 2015-06-19 2022-09-06 赛拉预测公司 Biomarker pairs for predicting preterm birth
EP3331572A4 (en) * 2015-08-04 2019-05-01 CD Diagnostics, Inc. Methods for detecting adverse local tissue reaction (altr) necrosis
AU2018317902A1 (en) 2017-08-18 2020-03-05 Sera Prognostics, Inc. Pregnancy clock proteins for predicting due date and time to birth

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5516702A (en) * 1991-11-06 1996-05-14 Adeza Biomedical Corporation Screening method for identifying women at increased risk for imminent delivery
US5541291A (en) * 1984-12-31 1996-07-30 Duke University Methods and compositions useful in the diagnosis and treatment of autoimmune diseases
US5719060A (en) * 1993-05-28 1998-02-17 Baylor College Of Medicine Method and apparatus for desorption and ionization of analytes
US5972594A (en) * 1997-02-05 1999-10-26 University Of Pittsburgh Method for screening for reproductive tract inflammation and preeclampsia using neutrophil defensins
US5976832A (en) * 1995-03-06 1999-11-02 Tonen Corporation DNA encoding novel calcium-binding proteins
US6174664B1 (en) * 1997-02-05 2001-01-16 University Of Pittsburgh Screening method for inflammatory diseases using neutrophil defensins and lactoferrin
US6225047B1 (en) * 1997-06-20 2001-05-01 Ciphergen Biosystems, Inc. Use of retentate chromatography to generate difference maps

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4020006A (en) * 1975-08-14 1977-04-26 Icl/Scientific Fluid containing dispersed particles simulating leukocytes and method for producing same
US5455160A (en) * 1993-05-27 1995-10-03 Fagerhol; Magne K. Diagnostic test and kit for disease or disorders in the digestive system
US6020208A (en) * 1994-05-27 2000-02-01 Baylor College Of Medicine Systems for surface-enhanced affinity capture for desorption and detection of analytes
US5545616A (en) * 1994-09-22 1996-08-13 Genentech, Inc. Method for predicting and/or preventing preterm labor
US5965354A (en) * 1995-07-28 1999-10-12 Chiron Corporation Herpes simplex virus diagnostics
CA2301451A1 (en) * 2000-03-20 2001-09-21 Thang T. Pham Method for analysis of analytes by mass spectrometry
US20030175713A1 (en) * 2002-02-15 2003-09-18 Clemens Sorg Method for diagnosis of inflammatory diseases using CALGRANULIN C
US7191068B2 (en) * 2003-03-25 2007-03-13 Proteogenix, Inc. Proteomic analysis of biological fluids
US8068990B2 (en) * 2003-03-25 2011-11-29 Hologic, Inc. Diagnosis of intra-uterine infection by proteomic analysis of cervical-vaginal fluids

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5541291A (en) * 1984-12-31 1996-07-30 Duke University Methods and compositions useful in the diagnosis and treatment of autoimmune diseases
US5516702A (en) * 1991-11-06 1996-05-14 Adeza Biomedical Corporation Screening method for identifying women at increased risk for imminent delivery
US5719060A (en) * 1993-05-28 1998-02-17 Baylor College Of Medicine Method and apparatus for desorption and ionization of analytes
US5976832A (en) * 1995-03-06 1999-11-02 Tonen Corporation DNA encoding novel calcium-binding proteins
US6313267B1 (en) * 1995-03-06 2001-11-06 Advanced Life Science Institute, Inc. Calcium-binding proteins
US5972594A (en) * 1997-02-05 1999-10-26 University Of Pittsburgh Method for screening for reproductive tract inflammation and preeclampsia using neutrophil defensins
US6174664B1 (en) * 1997-02-05 2001-01-16 University Of Pittsburgh Screening method for inflammatory diseases using neutrophil defensins and lactoferrin
US6225047B1 (en) * 1997-06-20 2001-05-01 Ciphergen Biosystems, Inc. Use of retentate chromatography to generate difference maps

Non-Patent Citations (10)

* Cited by examiner, † Cited by third party
Title
HEINE R.P. ET AL: "Amniotic fluid defensins: Potential markers of subclinical intrauterine infection", CLINICAL INFECTIOUS DISEASES, vol. 27, 1998, pages 513 - 518, XP008004444 *
HITOMI J. ET AL: "A novel calcium-binding protein in amniotic fluid, CAAF1: its molecular cloning and tissue distribution", JOURNAL OF CELL SCIENCE, vol. 109, 1996, pages 805 - 815, XP002043586 *
HOFMANN M.A. ET AL: "RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/Calgranulin polypeptides", CELL, vol. 97, 1999, pages 889 - 901, XP002935188 *
KRONE J.R. ET AL: "BIA/MS: Interfacing biomolecular interaction analysis with mass spectrometry", ANALYTICAL BIOCHEMISTRY, vol. 244, 1997, pages 124 - 132, XP002978973 *
PANYUTICH A.V. ET AL: "An enzyme immunoassay for human defensins", JOURNAL OF IMMUNOLOGICAL METHODS, vol. 141, 1991, pages 149 - 155, XP001073927 *
PASSEY R.J. ET AL: "A null mutation in the inflammation-associated S100 protein S100A8 causes early resorption of the mouse embryo", THE JOURNAL OF IMMUNOLOGY, vol. 163, 1999, pages 2209 - 2216, XP002978974 *
ROBINSON M.J. & HOGG N.: "A comparison of human S100A12 with MRP-14 (S100A9)", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, vol. 275, 2000, pages 865 - 870, XP002978972 *
See also references of EP1578205A4 *
VOGL T. ET AL: "S100A12 is expressed exclusively by granulocytes and acts independently from MRP8 and MRP14", THE JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 274, no. 36, 1999, pages 25291 - 25296, XP002978975 *
YANG Z. ET AL: "Proinflammatory properties of the human S100 protein S100A12", JOURNAL OF LEUKOCYTE BIOLOGY, vol. 69, June 2001 (2001-06-01), pages 986 - 994, XP009019576 *

Also Published As

Publication number Publication date
WO2004043238A2 (en) 2004-05-27
JP2006511790A (en) 2006-04-06
WO2004045379A2 (en) 2004-06-03
AU2003290984A8 (en) 2004-06-15
EP1578205A4 (en) 2008-01-02
US20040241775A1 (en) 2004-12-02
WO2004043238A8 (en) 2005-06-16
WO2004045379A3 (en) 2004-07-29
AU2003290984A1 (en) 2004-06-15
US20060127962A1 (en) 2006-06-15
AU2003290775A1 (en) 2004-06-03
AU2003290775A8 (en) 2004-06-03
EP1578205A2 (en) 2005-09-28

Similar Documents

Publication Publication Date Title
WO2004043238A8 (en) Biomarkers for intra-amniotic inflammation
IL149662A (en) Electrochemical methods and devices for use in the determination of hematocrit corrected analyte concentrations
AU2003218320A1 (en) Methods and systems for detecting, measuring, and monitoring stress in speech
HK1070942A1 (en) Method for reducing effect of hematocrit on measurement of an analyte in whole blood, and test kit and test article useful in the method
TW200616578A (en) Fluid handling devices
WO2006066008A3 (en) Device and methods for identifying and treating aspirin non-responsive patients
PL1728526T3 (en) System for monitoring the pressure in a blood line and a device to be used with such a system
MX2008001643A (en) Method of preserving the function of insulin-producing cells.
TW200617341A (en) Conducting liquid crystal polymer matrix comprising carbon nanotubes, use thereof and method of fabrication
ATE443867T1 (en) METHOD FOR PREDICTING SEPSIS IN A PATIENT WITH SYSTEMIC INFLAMMATORY RESPONSE SYNDROME (SIRS)
WO2005109154A3 (en) Method for rapid port power reduction
AU2003292699A1 (en) Analyzing system, analyzing method in that system, and system for collecting examination results used for analyzing
IL190206A0 (en) Method for lowering blood pressure in pre-hypertensive individuals and/or individuals with metabolic syndrome
AU2003248096A1 (en) Mix-in structure for gas or the like in pressurization centrifugal pump
WO2004098634A3 (en) Protein arginine n-methyltransferase 2 (prmt-2)
WO2006001911A3 (en) Crystal structure of the hepatocyte growth factor beta chain and methods of use
WO2005014783A3 (en) Reducing axon degeneration with proteasome inhibitors
WO2006135811A3 (en) Method of use of antagonists of zonulin to prevent the loss of or to regenerate pancreatic cells
WO2005094338A3 (en) Treatment of type 1 diabetes with inhibitors of macrophage migration inhibitory factor
ATE463743T1 (en) MONITORING HEART FAILURE
AU2003216766A1 (en) Method and device for use in micturition studies
WO2004016739A3 (en) Cell modulation using a cytoskeletal protein
WO2007081777A3 (en) METHODS FOR ACCURATELY MEASURING FREE IgE IN THE PRESENCE OF AN ANTI-IgE THERAPEUTIC
WO2005020984A3 (en) Method of reducing the risk of oxidative stress
WO2009131963A3 (en) Method and kit for assessing the suitability of erythrocytes for transfusion

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2004552155

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2003783358

Country of ref document: EP

CFP Corrected version of a pamphlet front page

Free format text: UNDER (54) PUBLISHED TITLE REPLACED BY CORRECT TITLE

WWP Wipo information: published in national office

Ref document number: 2003783358

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2006127962

Country of ref document: US

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 10534694

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 10534694

Country of ref document: US